Humacyte, Inc. (HUMA)
USD 3.54
(-6.72%)
USD 3.54
(-6.72%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -73.3 Million | -71.12 Million | -81.19 Million | -55.56 Million | -71.78 Million |
| Net Income | -110.77 Million | -11.96 Million | -26.47 Million | -66.52 Million | -85.42 Million |
| Depreciation & Amortization | 7.71 Million | 8.21 Million | 8.24 Million | 8.35 Million | 6.74 Million |
| Deferred income taxes | -4.84 Million | -173 Thousand | -17.8 Million | 177 Thousand | -4.27 Million |
| Stock-based compensation | 6.82 Million | 6.18 Million | 10.14 Million | 4.69 Million | 4.45 Million |
| Change in working capital | 6.57 Million | 1.02 Million | -557 Thousand | -2.36 Million | 453 Thousand |
| Other non-cash items | 21.19 Million | -74.41 Million | -54.74 Million | 103 Thousand | 1.97 Million |
| Investing Cash Flow | -173 Thousand | 4.84 Million | -8.22 Million | -268 Thousand | -8.12 Million |
| Investments in PPE | -2.28 Million | -1.04 Million | -220 Thousand | -318 Thousand | -8.12 Million |
| Acquisitions | - | -5.89 Million | - | 50 Thousand | - |
| Investment purchases | - | -10.1 Million | -8 Million | - | - |
| Sales/Maturities of investments | 2.1 Million | 16 Million | - | - | - |
| Other Investing Activities | 2.1 Million | 5.89 Million | -8 Million | 50 Thousand | - |
| Financing Cash Flow | 4.5 Million | -1.44 Million | 266.98 Million | 2.05 Million | -74 Thousand |
| Debt repayment | -5.7 Million | -1.98 Million | -1.72 Million | -1.5 Million | -1.29 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 566 Thousand | 535 Thousand | 598 Thousand | 301 Thousand | - |
| Other Financing Activities | -1.76 Million | -1.44 Million | 268.11 Million | 3.25 Million | 1.21 Million |
| Accounts receivables | 31 Thousand | 145 Thousand | -63 Thousand | 488 Thousand | -185 Thousand |
| Accounts payables | 4.81 Million | -509 Thousand | -197 Thousand | -889 Thousand | 2.43 Million |
| Inventory | - | - | -181 Thousand | -2.25 Million | -2.43 Million |
| Other working capital | 1.72 Million | 1.39 Million | -116 Thousand | 289 Thousand | 638 Thousand |
| Cash at beginning of period | 149.77 Million | 217.5 Million | 39.92 Million | 93.71 Million | 173.69 Million |
| Cash at end of period | 80.59 Million | 149.77 Million | 217.5 Million | 39.92 Million | 93.71 Million |
| Capital Expenditure | -2.28 Million | -1.04 Million | -220 Thousand | -318 Thousand | -8.12 Million |
| Effect of forex changes on cash | -209 Thousand | - | - | - | 173.69 Million |
| Net cash flow / Change in cash | -69.18 Million | -67.73 Million | 177.57 Million | -53.78 Million | -79.98 Million |
| Free Cash Flow | -75.58 Million | -72.17 Million | -81.41 Million | -55.88 Million | -79.91 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -56.66 Million | -31.89 Million | -25.1 Million | -110.77 Million | -25.99 Million | -22.7 Million |
| Depreciation & Amortization | 1.82 Million | 1.79 Million | 3.37 Million | 7.71 Million | 1.83 Million | 1.98 Million |
| Deferred income taxes | - | - | -4.64 Million | -4.84 Million | 135 Thousand | 2.48 Million |
| Stock-based compensation | 1.43 Million | 1.45 Million | 1.4 Million | 6.82 Million | 1.77 Million | 1.84 Million |
| Change in working capital | 4.05 Million | -4.66 Million | 3.13 Million | 6.57 Million | 7.05 Million | -3.45 Million |
| Other non-cash items | 30.82 Million | 13.94 Million | 2.78 Million | 21.19 Million | 2.2 Million | -2.75 Million |
| Investing Cash Flow | -184 Thousand | -391 Thousand | -150 Thousand | -173 Thousand | -493 Thousand | 1.62 Million |
| Investments in PPE | -184 Thousand | -391 Thousand | -150 Thousand | -2.28 Million | -493 Thousand | -485 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 2.1 Million | - | 2.1 Million |
| Other Investing Activities | - | - | - | 2.1 Million | - | 2.1 Million |
| Financing Cash Flow | -467 Thousand | 62.79 Million | -335 Thousand | 4.5 Million | -764 Thousand | 6.01 Million |
| Debt repayment | -404 Thousand | -603 Thousand | -38.78 Million | -5.7 Million | -577 Thousand | -32.06 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 787 Thousand | 43.39 Million | 253 Thousand | 566 Thousand | 99 Thousand | 95 Thousand |
| Other Financing Activities | -850 Thousand | 20 Million | -39.37 Million | -1.76 Million | -286 Thousand | 37.98 Million |
| Accounts receivables | - | - | - | 31 Thousand | - | - |
| Accounts payables | 2.31 Million | -2.94 Million | 3.51 Million | 4.81 Million | 526 Thousand | 467 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.74 Million | -1.71 Million | -388 Thousand | 1.72 Million | 6.52 Million | -3.91 Million |
| Cash at beginning of period | 115.5 Million | 80.59 Million | 100.13 Million | 149.77 Million | 114.6 Million | 129.57 Million |
| Cash at end of period | 93.56 Million | 115.5 Million | 80.59 Million | 80.59 Million | 100.34 Million | 114.6 Million |
| Capital Expenditure | -184 Thousand | -391 Thousand | -150 Thousand | -2.28 Million | -493 Thousand | -485 Thousand |
| Effect of forex changes on cash | - | - | 1000.00 | -209 Thousand | - | - |
| Net cash flow / Change in cash | -21.94 Million | 34.91 Million | -19.53 Million | -69.18 Million | -14.26 Million | -14.96 Million |
| Free Cash Flow | -21.47 Million | -27.73 Million | -19.2 Million | -75.58 Million | -13.5 Million | -23.08 Million |
TTNM
RAD
CEN
1341
GLPI
0536